The present invention provides identification of a thirty-five gene set that predicts the anticancer activity of inhibitors of the RAF/MEK/MAPK pathway, methods of qualifying cancer status in a subject, methods of identifying an anti-tumor response in a subject, methods of monitoring the efficacy of a therapeutic drug in a subject, and methods of identifying an agent useful in the treatment of a cancer based on expression of the thirty-five gene set.

 
Web www.patentalert.com

< COMPOSITIONS AND KITS FOR COMPOUNDING PHARMACEUTICALS

> Alleles of the opcA Gene from Coryneform Bacteria

~ 00438